Journal Article

Reevaluation of Antibiotic Breakpoints

Ian Phillips

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 33, issue Supplement_3, pages S230-S232
Published in print September 2001 | ISSN: 1058-4838
Published online September 2001 | e-ISSN: 1537-6591 | DOI:
Reevaluation of Antibiotic Breakpoints

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology


Show Summary Details


Differences in antibiotic breakpoints have resulted from differences in clinical practice and in interpretation of the parameters that are considered when breakpoints are set. Differences in the first of these are less common for newer agents, whereas differences in the latter could be resolved by consensus discussions. Greater difficulty arises when common pathogens acquire resistance, especially when this occurs by degrees, as has happened with penicillin for gonococci and the pneumococci, and for the fluoroquinolones in relation to a wide variety of bacterial species. Changes to breakpoints under such circumstances should be introduced only after the most careful consideration and the education of diagnostic microbiologists and clinicians.

Journal Article.  1796 words. 

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.